Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...
COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, announced today the successful ...
OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS’ CAR-T programs.
Beijing Zhongke Journal Publising Co. Ltd. This study is led by Professor Zhenghe Li (State Key Laboratory of Rice Biology and breeding, Institute of Biotechnology, Zhejiang University, Hangzhou, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results